Your browser doesn't support javascript.
loading
Simultaneous Follicular Lymphoma and Myelofibrosis: Report of a Case with Review of the Literature.
Kong, Ling-Zhijie; Li, Jing; Wang, Rui-Cang; Kang, Lin; Wei, Qiang; Li, Yan.
Afiliación
  • Kong LZ; Department of Haematology, Hebei General Hospital, Shijiazhuang, Hebei, People's Republic of China.
  • Li J; Hebei North University, Zhangjiakou, Hebei, People's Republic of China.
  • Wang RC; Department of Hematology, Hebei Province Hospital of Chinese Medicine, Shijiazhuang, Hebei, People's Republic of China.
  • Kang L; Department of Haematology, Hebei General Hospital, Shijiazhuang, Hebei, People's Republic of China.
  • Wei Q; Department of Pathology, Hebei General Hospital, Shijiazhuang, Hebei, People's Republic of China.
  • Li Y; Department of Nuclear Medicine, Hebei General Hospital, Shijiazhuang, Hebei, People's Republic of China.
Onco Targets Ther ; 14: 4551-4559, 2021.
Article en En | MEDLINE | ID: mdl-34466001
BACKGROUND: Myelofibrosis (MF) is often associated with chronic myeloid leukemia, myelodysplastic syndrome and primary myeloproliferative neoplasms (MPN), but few number cases of malignant lymphoma with myelofibrosis was reported, and a few cases about follicular lymphoma with MF were found. Here we described a case of follicular lymphoma (FL) complicated by myelofibrosis. CASE PRESENTATION: A 43-year-old man was diagnosed with follicular lymphoma (FL) complicated by MF, besides, the lymphoma staging of this patient was AnnArbor IV B. The cytokines of plated-derived growth factor (PDGF), basic fibroblast growth factor (b-FGF), vascular endothelial growth factor (VEGF), tumor necrosis factor α (TNF-α), interleukin-1ß (IL-1ß), interleukin-2 (IL-2), and transforming growth factor-ß (TGF-ß) were positive, while JAK2V617F, MPL, and CALR mutations were negative. After first course of chemotherapy, the peripheral blood and MF improved. The systemic superficial lymph nodes and spleen were significantly narrowed after the third cycle of chemotherapy. CONCLUSION: The production of various cytokines, such as b-FGF, TNF-α, TGF-ß, PDGF, IL-1ß, IL-2, IL-6, IL-10, may contribute to the development of MF.
Palabras clave

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Idioma: En Revista: Onco Targets Ther Año: 2021 Tipo del documento: Article Pais de publicación: Nueva Zelanda

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Idioma: En Revista: Onco Targets Ther Año: 2021 Tipo del documento: Article Pais de publicación: Nueva Zelanda